Видео ютуба по тегу Cytokinetics

Cytokinetics Aficamten: FDA Approval Sets Stage for $10B HCM Market Clash
Cytokinetics Aficamten: FDA Approval Sets Stage for $10B HCM Market Clash
Cytokinetics (CYTK Stock) FDA Approves MyQorzo (aficamten) Obstructive Hypertrophic Cardiomyopathy
Cytokinetics (CYTK Stock) FDA Approves MyQorzo (aficamten) Obstructive Hypertrophic Cardiomyopathy
Cytokinetics MYQORZO FDA Approval: A Heart Disease Breakthrough!
Cytokinetics MYQORZO FDA Approval: A Heart Disease Breakthrough!
Cytokinetics Investor Conference Call on FDA Approval of MYQORZO™ | Dec 19, 2025
Cytokinetics Investor Conference Call on FDA Approval of MYQORZO™ | Dec 19, 2025
Компания Cytokinetics Inc. (CYTK): коммерциализация и рыночные перспективы в области лечения кард...
Компания Cytokinetics Inc. (CYTK): коммерциализация и рыночные перспективы в области лечения кард...
LIVE: Cytokinetics Big Announcement with Lisa and Dr. Martin Maron 📱
LIVE: Cytokinetics Big Announcement with Lisa and Dr. Martin Maron 📱
LIVE: Cytokinetics Big Announcement with Lisa and Dr. Martin Maron
LIVE: Cytokinetics Big Announcement with Lisa and Dr. Martin Maron
CYTK Cytokinetics Stock: Monday Predicted Opening Price (Dec 22) - 5 Key Moves After FDA Win? 🚨
CYTK Cytokinetics Stock: Monday Predicted Opening Price (Dec 22) - 5 Key Moves After FDA Win? 🚨
Cytokinetics, Incorporated CYTK Q3 2025 Earnings Call
Cytokinetics, Incorporated CYTK Q3 2025 Earnings Call
Networking & Mentorship
Networking & Mentorship
Cytokinetics CEO: Advancing a next gen opportunity which could expand addressable market
Cytokinetics CEO: Advancing a next gen opportunity which could expand addressable market
Learning & Growth
Learning & Growth
Culture
Culture
264% прибыли + 4,5 млн долларов США от торговли акциями Cytokinetics (CYTK): безрисковая стратегия?
264% прибыли + 4,5 млн долларов США от торговли акциями Cytokinetics (CYTK): безрисковая стратегия?
Cytokinetics Q2 2025 Earnings: Huge Revenue Beat but Stock Dips?
Cytokinetics Q2 2025 Earnings: Huge Revenue Beat but Stock Dips?
Cytokinetics Q2 2025: Massive Revenue Beat & Crucial September Catalysts
Cytokinetics Q2 2025: Massive Revenue Beat & Crucial September Catalysts
Cytokinetics CYTK Q2 2025 Earnings Call
Cytokinetics CYTK Q2 2025 Earnings Call
Cytokinetics Primary Results from MAPLE-HCM | Sep 02, 2025
Cytokinetics Primary Results from MAPLE-HCM | Sep 02, 2025
Cytokinetics Stock Analysis
Cytokinetics Stock Analysis
CYTK Cytokinetics Stock Analysis: 3 Price Targets After Sep 2 Aficamten Data - Will It Surge? 🚀
CYTK Cytokinetics Stock Analysis: 3 Price Targets After Sep 2 Aficamten Data - Will It Surge? 🚀
사이토키네틱스 Cytokinetics Inc. (CYTK)기업 분석
사이토키네틱스 Cytokinetics Inc. (CYTK)기업 분석
$CYTK Cytokinetics, Inc. - 60 Second Analysis - August 30, 2025 #cytk #cytokinetics #stockmarket
$CYTK Cytokinetics, Inc. - 60 Second Analysis - August 30, 2025 #cytk #cytokinetics #stockmarket
My Key Takeaway on Cytokinetics' Director Appointment
My Key Takeaway on Cytokinetics' Director Appointment
Cytokinetics Q2 2025 Earnings Call
Cytokinetics Q2 2025 Earnings Call
Ep173: Robert Blum on Building a Fully Integrated Biopharma For Muscle Disorders
Ep173: Robert Blum on Building a Fully Integrated Biopharma For Muscle Disorders